A prospective study comparing highly qualified Molecular Tumor Boards with AI-powered software as a medical device.
Bando H, Naito Y, Yamada T, Fujisawa T, Imai M, Sakamoto Y, Saigusa Y, Yamamoto K, Tomioka Y, Takeshita N, Sunami K, Futamura M, Notake C, Aoki S, Okano K, Yoshino T.
Bando H, et al. Among authors: sakamoto y.
Int J Clin Oncol. 2024 Dec 23. doi: 10.1007/s10147-024-02684-z. Online ahead of print.
Int J Clin Oncol. 2024.
PMID: 39714567
Review.